Table 4

Association of prebronchodilator and postbronchodilator spirometric measures with number of exacerbations and severe exacerbations per year, change in FEV1, dyspnoea scores and distance covered in 6 min walk test from phase 1 to phase 2 visit (5-year interval)

Prebronchodilator FEV1/FVC <0.7 (PREO)Postbronchodilator FEV1/FVC <0.7 (POSTO)
Coef (95% CI)P valueAICCoef (95% CI)P valueAIC
Exacerbations per year0.35 (0.31 to 0.4)<0.001−8930.38 (0.34 to 0.43)<0.001−929
Severe exacerbations per year0.14 (0.11 to 0.16)<0.001−116080.14 (0.12 to 0.16)<0.001−11614
Change in FEV1, mL−2.25 (−20.3 to 15.8)0.8154 31710 (−7.26 to 29.3)0.2454 315
Change in MMRC0.2 (0.12 to 0.27)<0.00119780.21 (0.13 to 0.29)<0.0011974
Change in SGRQ1.92 (0.99 to 2.85)<0.00126 3992.56 (1.62 to 3.5)<0.00126 387
Change in 6-MWD, feet−22.2 (−44.3 to 0.05)0.04955 763−33.2 (−55.6 to 10.8)0.00455 758